Table 2.

Independent association of triglyceride-glucose index and NT-proBNP categories with incident MACCEs

	Base Model†		Adjusted Model††
	Hazard Ratio (95% CI)	P Value	Hazard Ratio (95% CI)	P Value
NT-proBNP		< 0.001		< 0.001
Tertile 1	1.00 (Reference)		1.00 (Reference)
Tertile 2	1.53 (1.27‒1.86)	< 0.001	1.30 (1.04‒1.63)	0.020
Tertile 3	2.89 (2.41‒3.45)	< 0.001	1.95 (1.50‒2.54)	< 0.001
TyG index, per 1 unit*	1.16 (1.05‒1.27)	0.002	1.18 (1.05‒1.32)	0.004

^*Modeled as linear effects

^†Base model included the TyG index, NT-proBNP, age, and sex

^††Adjusted model included base model plus BMI, diagnosis of AMI, history of hypertension, history of dyslipidemia, history of myocardial infarction, history of arrhythmia, SBP, LVEF, eGFR, hs-CRP, LDL-C, smoking status, and in-hospital treatments (PCI, antiplatelet therapy, β-blocker, ACEI or ARB, and statins)

NT-proBNP, N-terminal pro-B-type natriuretic peptide; MACCEs, major adverse cardio-cerebral events; CI, confidence interval; TyG, triglyceride-glucose; BMI, body mass index; AMI, acute myocardial infarction; SBP, systolic blood pressure; LVEF, left ventricular ejection fraction; eGFR, estimated glomerular filtration rate; hs-CRP, high sensitivity C-reactive protein; LDL-C, low-density lipoprotein cholesterol; PCI, percutaneous coronary intervention; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker